深圳市医保局牵头组织的颅内球囊扩张导管、颅内支架、神经介入抽吸导管、颅内取栓支架、神经介入经桡动脉导管和神经介入微导管等六类医用耗材省级带量联动采购顺利产生中选结果1。本次集采聚焦神经介入手术的关键器械，覆盖全省公立医疗机构和驻粤军队医疗机构，全省年采购规模超11亿元，采购周期为2年1。
此次采购中，74家企业的13033个规格型号产品成功中选1，企业中选率达98.67%1。史赛克、强生、微创神通、赛诺医疗等主要厂商参与其中1。通过确定采购量为企业提供销售托底，本次集采推动临床主流神经介入耗材实现大幅降价1，旨在减轻脑卒中患者的就医负担1。
Shenzhen's Medical Insurance Bureau has successfully completed a provincial-level volume purchase initiative for six categories of neurovascular intervention devices, including intracranial balloon angioplasty catheters, with results announced and products selected for procurement 1. The purchasing program covers all public medical institutions and military hospitals across Guangdong Province, encompassing an annual procurement volume exceeding 1.1 billion yuan across a two-year cycle 1. A total of 74 enterprises secured contracts with 13,033 distinct product specifications selected for purchase 1.
The procurement initiative specifically targets key instruments used in neurovascular intervention surgery 1. The six device categories covered are intracranial balloon angioplasty catheters, intracranial stents, neurovascular aspiration catheters, intracranial thrombectomy stents, transradial neurovascular catheters, and neurovascular microcatheters 1. Major manufacturers including Stryker, Johnson & Johnson, MicroPort NeuralWorks, and Sino Medical Sciences secured placements in the procurement program 1. Through this volume-based purchasing arrangement, the initiative aims to drive substantial price reductions in mainstream neurovascular intervention devices while guaranteeing procurement volumes to provide market certainty for suppliers, ultimately reducing the medical burden on patients with cerebral stroke 1.
评论
还没有评论，欢迎留下第一条。